Catherine Thompson

Dr. Thompson has extensive experience in drug and device development both within the pharma industry and as a successful consultant (founder of June Pharma Consulting, VP International Drug Development at BlueReg Pharma Consulting). She previously spent nearly 25 years in the pharmaceutical industry (Allergan, Eisai, Schwartz Pharma) where her roles included being responsible for global drug development programs throughout their lifecycle. Dr. Thompson has a proven track record in both development strategy and hands-on operational experience which has led to many successful agency negotiations and approvals. She has also authored many publications in peer-reviewed scientific/medical journals. Dr. Thompson received both her PhD and undergraduate degrees in Biological Sciences from the University of Birmingham and resides in France.